Monday, 3 June 2024

Railway Telematics Market Poised to Expand at a Robust Pace of $18.37 Billion Over 2030: Grand View Research Inc.

Railway Telematics Market Growth & Trends

The global railway telematics market is expected to reach USD 18.37 billion by 2030, registering a CAGR of 6.7% from 2023 to 2030, according to Grand View Research, Inc. Increase in government initiatives for smart railways owing to rapid urbanization and evolution of smart cities, globally, is driving the market growth. Governments across the globe are laying emphasis on undertaking several smart city initiatives to speed up operational activities in public transport services and offer better infrastructure for transportation.

Several countries such as Germany, India, France, and Canada have recognized that the expansion of the railway infrastructure is a significant factor supporting economic development. As a result, OEMs and numerous countries are investing considerably in railway infrastructure. For instance, in September 2022, Siemens mobility announced a contract with NS Groep N.V., a transportation company, to upgrade 176 ViRM trains with the most up-to-date ETCS European Train Control System (ETCS) Level 2 technology.

With the ETCS Level 2 update, the fleet will be able to function more effectively to balance its useful life while also satisfying the most recent European criteria for rail safety compatibility. Equipment for the ETCS onboard unit, installation assistance, and seven years of system maintenance services will all be supplied by Siemens Mobility.

The majority of the prominent players in the railway telematics market belong to European region. OEMs including Alstom, DB Cargo, Knorr-Bremse, and Siemens AG hold a majority of the share in the railway telematics market. Several railway operators are replacing old technologies with progressive train signaling and control systems. For instance, in May 2022, Rail Pulse announced a partnership with Railinc, a rail data services provider company.

Under this partnership, Railinc and Rail Pulse will provide sensor and telematics technology to the North American freight rail sector. Under a 10-year agreement, Railinc will create, maintain, and run the technology platform for Rail Pulse to track the current location, and condition of railcars.

The outbreak of COVID-19 has negatively impacted the market. The lockdown restrictions imposed by the various governments have hampered freight and logistics activities, globally, during the first half of 2020. This has led to a significant decline in the adoption of telematics services. However, with the ease in the lockdown restrictions imposed by various governments, globally, and the revival of logistics and freight activities along with the business resumption, the market is expected to witness significant growth during the forecast period.

The prominent players that dominated the railway telematics market globally in 2020 include Hitachi Ltd., Siemens AG, Robert Bosch GmbH, Knorr-Bremse AG, and Alstom SA. These players majorly focus on strategic partnerships and mergers & acquisitions to enhance their business operations. For instance, in January 2022, Hitachi Rail Limited partnered with Intermodal Telematics BV (IMT), a software services provider for the intermodal transport industry, to improve its rail freight market offerings.

As part of this partnership, IMT's monitoring sensors that provide real-time monitoring will be integrated into Hitachi's present digital freight service. These sensors support the accurate verification of railcar locations, loading status, door and hatch open/close conditions, cargo temperature and pressure, along with the condition of bogies and wheelsets.

Request a free sample copy or view report summary: Railway Telematics Market Report

Railway Telematics Market Report Highlights

  • The fleet management segment is expected to dominate the railway telematics market due to the increasing freight activities, globally. The segment growth can be attributed to the rising need to manage the performance and the condition of rail assets
  • The telematics control unit segment is expected to dominate the component segment and the trend is expected to continue during the forecast period. The growth can be attributed to the increased profitability, safety, and maintenance provided by the advanced telematics control unit in railcars
  • North America is estimated to account for the majority share of the market during the forecast period. Growing transportation requirements of freight and logistics industries and increasing awareness about safety and accident prevention are some of the major drivers of the market growth in this region

Access Press Release@ https://www.grandviewresearch.com/press-release/global-railway-telematics-market

Railway Telematics Market Segmentation

Grand View Research has segmented the global railway telematics market based on solution, railcar, component, and region:

Railway Telematics Solution Outlook (Revenue, USD Million; 2018 - 2030)

  • Fleet Management
  • Automatic Stock Control
  • Remote Data Access
  • Railcar Tracking And Tracing
  • Others

Railway Telematics Railcar Outlook (Revenue, USD Million; 2018 - 2030)

  • Hoppers
  • Tank Cars
  • Well Cars
  • Boxcars
  • Refrigerated Boxcars
  • Others

Railway Telematics Component Outlook (Revenue, USD Million; 2018 - 2030)

  • Telematics Control Unit
  • Sensors

Railway Telematics Regional Outlook (Revenue, USD Million; 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • France
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa

List of key players in the Railway Telematics Market

  • Siemens AG
  • Hitachi Ltd.
  • Alstom SA
  • Knorr-Bremse AG
  • Robert Bosch GmbH
  • A1 Digital
  • Rail nova SA
  • SAVVY Telematics Systems AG
  • Wabtec Corporation
  • Amsted Industries
  • Orbcomm

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Non-alcoholic Beverages Market to Witness Exponential Growth by 2030: Grand View Research Inc.

 Non-alcoholic Beverages Market Growth & Trends

The global non-alcoholic beverages market size is expected to reach USD 1,997.25 billion by 2030, registering a CAGR of 7.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. As consumers become more health-conscious, there is a growing demand for beverages that offer nutritional benefits, such as hydration, and contribute to overall well-being. This trend has shifted the spotlight from traditional sugary and carbonated drinks to healthier and functional beverage options.

Consumers increasingly seek alternatives to sugary sodas and high-calorie beverages, driven by concerns about obesity, diabetes, and other health issues. Non-alcoholic drinks that promote natural ingredients, low or no sugar content, and functional additives such as vitamins, antioxidants, and probiotics are gaining popularity. Companies in the market respond to this demand by innovating and introducing a diverse range of healthier beverage options, including herbal teas, infused water, natural fruit juices, and functional drinks.

The rise of alternative and plant-based ingredients is contributing to the growth of this market. Plant-based beverages, such as almond milk, soy milk, and other dairy alternatives, have gained traction as consumers explore options that align with their dietary preferences, including vegan and lactose-free choices. Health considerations and environmental and ethical concerns drive this shift toward plant-based and alternative ingredients.

The retail stores have become integral to the global economy in recent years. These stores have a competitive advantage in terms of proximity to customers and, in most cases, an extremely loyal customer base. Retail sales growth has thus become a major factor in the growth of the market.

For instance, in 2022, Koios Beverage Corporation, a beverage manufacturer, partnered with McLane Co., a company that buys, sells, and delivers more than 50,000 consumer products to nearly 110,000 locations across the U.S. This helped the former to grow its distribution network for its Fit Soda line (organic, natural soda) in convenience stores and gas stations in the U.S. Furthermore, the company is expanding its footprint in many new markets and regions.

Request a free sample copy or view report summary: Non-alcoholic Beverages Market Report

Non-alcoholic Beverages Market Report Highlights

  • Based on product, the carbonated soft drinkssegment dominated the market in 2023. As consumers seek less sugar in beverages, several manufacturers are diversifying their product offerings by providing zero and low-calorie products to prompt growth within this category
  • Based on distribution channel, the retail segment is expected to grow at the fastest CAGR from 2024 to 2030. Several brands are launching innovative products such as mock tails, artisanal sodas, and other non-alcoholic products through retail channels such as supermarkets, convenience, and department stores. These retail channels offer various options to accommodate different tastes and preferences. Moreover, retailers usually dedicate shelf space for non-alcoholic beverages, further increasing their visibility and potential for sales
  • Asia Pacific dominated the overall non-alcoholic beverages industry in 2023. Asia Pacific, particularly in emerging countries, has created a strong demand for non-alcoholic beverages, including energy drinksand fortified juices. The growing awareness of the need for an active lifestyle, given the prevalence of lifestyle diseases, has encouraged consumers to opt for healthy and sugar-free drinks

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nonalcoholic-beverage-market

Non-alcoholic Beverages Market Segmentation

Grand View Research has segmented the global non-alcoholic beverages market based on product, distribution channel, and region:

Non-alcoholic Beverages Product Outlook (Revenue, USD Billion, 2018 - 2030)

  • Carbonated Soft Drinks
  • Bottled Water
  • RTD Tea & Coffee
  • Functional Beverages
  • Juices
  • Dairy-based Beverages
  • Others

Non-alcoholic Beverages Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)

  • Food Service
  • Retail

Non-alcoholic Beverages Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
  • Central & South America
    • Brazil
  • Middle East & Africa
    • South Africa

List of Key Players in the Non-alcoholic Beverages Market

  • NestlĂ©
  • PepsiCo
  • Unilever
  • Keurig Dr. Pepper Inc.
  • The Coca-Cola Company
  • Jones Soda Co.
  • Danone S.A
  • Suntory Beverage & Food Ltd
  • Asahi Group Holdings, Ltd.
  • Red Bull

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Australia & New Zealand Healthcare CROs Market Projected to Discern Stable Expansion by 2030

 Australia & New Zealand Healthcare CROs Market Growth & Trends

The Australia & New Zealand healthcare CROs market size is expected to reach USD 2.4 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.5% from 2023 to 2030. The rising costs associated with drug development are anticipated to drive the demand. As clinical trial costs continue to increase and challenges related to patient recruitment persist, biopharmaceutical companies are increasingly turning to countries such as Australia, New Zealand, China, and India in search of cost savings and efficient patient recruitment. As a result, the market is expected to benefit from this trend over the forecast period.

R&D tax credits are available in both countries. According to the April 2021 update from Brandon Capital Partners, a key Australasian life sciences venture capital firm, the R&D tax incentive given to international sponsors in Australia can lead to savings in costs of up to 43.5%, in comparison to New Zealand's 15%. In addition, the article stated that the Australian government projected that its tax credit helped the clinical trial sector reach a value of USD 1 billion, which would eventually boost the Australia and New Zealand contract research organizations industry’s growth.

The growing adoption of digital health technologies, such as telemedicine, wearables, and AI, is impacting drug development & clinical trials, creating new opportunities for contract research organizations. Australia is one of the leading countries to conduct decentralized clinical trials; according to Novotech, During the COVID-19 pandemic, Australia demonstrated significant progress in online care platforms. From March 2020 to April 2021, more than 56 million telehealth services were provided to around 13.6 million patients. In addition, the government's recent 2021-2022 Federal Budget allocated an additional USD 204.6 million to telehealth, bringing the total investment to USD 3.6 billion.

Request a free sample copy or view report summary: Australia & New Zealand Healthcare CROs Market Report

Australia & New Zealand Healthcare CROs Market Report Highlights

  • Based on phase type, the clinical segment dominated the market in 2022, with the largest share of 76.4%, because it comprises four elaborate phases, including human subjects. The significant demand for new treatments has further contributed to the growth of the segment
  • The regulatory/medical affairs service segment is expected to register the fastest CAGR of 15.6% over the forecast period
  • The oncology application segment accounted for the largest market share of 40.2% owing to the increasing incidence of cancer, advancements in oncology research, and the growing demand for targeted therapies
  • Pharmaceutical & Biopharmaceutical companies by end-use segment is expected to register the fastest CAGR of 11.7% over the forecasted period

Access Press Release@ https://www.grandviewresearch.com/press-release/australia-new-zealand-healthcare-contract-research-organizations-market-analysis

Australia & New Zealand Healthcare CROs Market Segmentation

Grand View Research has segmented the Australia & New Zealand healthcare CROs market based on phase type, service, application, end-use, and country:

Australia & New Zealand Healthcare CROs Phase Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Drug Discovery
    • Target Validation
    • Lead Identification
    • Lead Optimization
  • Preclinical
  • Clinical
    • Phase I Trial Services
    • Phase II Trial Services
    • Phase III Trial Services
    • Phase IV Trial Services

Australia & New Zealand Healthcare CROs Service Outlook (Revenue, USD Million, 2018 - 2030)

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/ Assurance
  • Bio-statistics
  • Investigator Payments
  • Laboratory
  • Patient and site Recruitment
  • Technology
  • Others

Australia & New Zealand Healthcare CROs Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Oncology
  • Cardiovascular
  • Autoimmune/Inflammation
  • Central nervous system (CNS)
  • Dermatology
  • Infectious diseases
  • Respiratory
  • Others

Australia & New Zealand Healthcare CROs End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies

Australia & New Zealand Healthcare CROs Country Outlook (Revenue, USD Million, 2018 - 2030)

  • Australia
  • New Zealand

List of Key Players in the Australia & New Zealand Healthcare CROs Market

  • PAREXEL International Corporation
  • Thermo Fischer Scientific, Inc.
  • SGS SA
  • ICON plc
  • Medpace Australia Pty. Ltd
  • Charles River Laboratories International, Inc.
  • IQVIA
  • Novotech
  • Laboratory Corporation of America Holdings
  • Syneos Health

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Europe Transfer Molded Pulp Packaging Market Booming Trends and Forecast Assessment for the Period

 Europe Transfer Molded Pulp Packaging Market Growth & Trends

The Europe transfer molded pulp packaging market size is expected to reach USD 1.04 billion by 2030, expanding at a CAGR of 6.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growth of the Europe transfer molded pulp packaging industry is fueled by various factors, including the eco-friendly nature of transfer molded pulp, increasing consumer preference for recyclable materials, the rise in disposable incomes, and the growing demand for packaging that is both reusable and sustainable.

European countries such as Germany, France, Austria, Russia, and the UK are some of the major egg-producing countries globally. As the production and subsequent consumption of eggs continue to grow, there is a parallel need for sustainable packaging solutions to accommodate the packaging of these eggs. Transfer molded pulp packaging offers a protective and eco-friendly option for packaging eggs, ensuring their safe transportation and storage. Hence, the market is witnessing growth due to the rising demand for lightweight and cost-effective packaging solutions for the transportation of fragile products such as eggs.

The increasing consumption of on-the-go products and single-serve meals, driven by the growing number of working professionals in Europe and the desire for convenience, is expected to drive the demand for transfer molded pulp packaging products in the food service industry over the forecast period. The growing popularity can be attributed to the rise in the number of working professionals in European countries. According to Eurostat, the number of working professionals in Europe is expected to exceed 250 million, accounting for approximately 73.1% of the total population in 2021.

Additionally, the employment rate in all EU member states witnessed growth in 2022 compared to the previous year. This increase in the working population has led to a rising trend among consumers to opt for ready-to-eat meals, on-the-go snacks, and beverages from restaurants and fast-food chains, as they offer convenience and time-saving benefits.

The ban on plastic in European countries can be a significant factor driving the growth of the market. In October 2023, England introduced a ban on specific single-use plastic items, which prevents businesses from providing products such as polystyrene cups and plastic cutlery. This initiative is part of a larger goal to eliminate all "unnecessary plastic waste" entirely by 2042. As a result, this outlook is expected to boost demand for alternative packaging materials that are more sustainable and eco-friendly, such as transfer molded pulp packaging across the UK.

Request a free sample copy or view report summary: Europe Transfer Molded Pulp Packaging Market Report

Europe Transfer Molded Pulp Packaging Market Report Highlights

  • Based on application, the food packagingsegment dominated the market in 2023. Transfer molded pulp packaging products, such as wine shippers, trays, inserts, and divider sets are used for shipping wine or champagne. These packaging solutions provide a sustainable and eco-friendly alternative for transporting wine bottles
  • Healthcare is projected to be the fastest-growing segment of the market. The healthcare industry encounters notable obstacles in preventing cross-contamination among patients and staff, especially when it comes to managing human waste. The utilization of transfer molded pulp products, such as single-use urinals, dishes, and bowls can effectively mitigate this risk and enhance safety measures in healthcare settings
  • Western Europe dominated the region in 2023 and is expected to grow with the fastest growth rate over the forecast period. The demand for transfer molded pulp packaging products, including egg cartons and trays, is driven by the growing production and consumption of eggs in Western Europe. The rising consumption of wine in the region is also fueling the demand for fiber-molded wine or champagne shippers
  • In February 2023, Huhtamaki completed the acquisition of Huhtamaki Tailored Packaging Pty Ltd (HTP), a prominent Australian food service packaging distribution and wholesale group, thereby obtaining full ownership. Initially acquiring a majority stake in 2018, Huhtamaki already held approximately 76% ownership of the company prior to this transaction. The debt-free purchase price for the additional shares amounts to approximately USD 20 million

Access Press Release@ https://www.grandviewresearch.com/press-release/europe-transfer-molded-pulp-packaging-market-analysis

Europe Transfer Molded Pulp Packaging Market Segmentation

Grand View Research has segmented the Europe transfer molded pulp packaging market based on application and region:

Europe Transfer Molded Pulp Packaging Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Food Packaging
  • Food Service
  • Electronics
  • Healthcare
  • Industrial
  • Others

Europe Transfer Molded Pulp Packaging Region Outlook (Revenue, USD Million, 2018 - 2030)

  • Western Europe
    • Germany
    • France
    • Netherlands
    • Belgium
    • Austria
    • Slovakia
    • Czech Republic
    • Rest of Western Europe
  • Eastern Europe
    • Poland
    • Hungary
    • Romania
    • Rest of Eastern Europe
  • Scandinavian
    • Sweden
    • Denmark
    • Finland
    • Rest of Scandinavian

List of Key Players in the Europe Transfer Molded Pulp Packaging Market

  • Brødrene Hartmann A/S
  • Omni-Pac Group
  • Huhtamaki
  • Pulp-Tec Limited
  • TART
  • PAPACKS Sales GmbH
  • KIEFEL GmbH
  • James Cropper plc
  • TRIDAS
  • Goerner Formpack GmbH
  • buhl-paperform GmbH

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cut Flowers Market Size, Share, Trends, Analysis And Growth Forecast To 2030: Grand View Research Inc.

 Cut Flowers Market Growth & Trends

The global cut flowers market size is expected to reach USD 51.83 billion by 2030 and it is projected to grow at a CAGR of 4.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The cut flower market is witnessing significant shifts driven by evolving consumer preferences and market dynamics. A notable trend is the increasing use of cut flowers for various occasions such as weddings, celebrations, and cultural events, alongside a growing preference for locally grown and sustainable options, particularly in the Asia Pacific market. This demand for eco-friendly products has led to a surge in homegrown floriculture.

Owing to a stiff competition from international suppliers who offer lower prices and greater volume, U.S. flower farms are carving out a niche by focusing on speciality varieties not readily available from overseas distributors. These local growers are emphasizing high-quality stems, including delicate blooms that may not withstand long-distance shipping or have shorter vase lives, catering to discerning customers seeking unique offerings.

Among various flowers, roses are considered as timeless symbols of love and affection, remain immensely popular across various occasions, driving demand for cut flowers. Their diverse colors and versatility in arrangements further contribute to their appeal among consumers.

Small-scale cut flower farms, characterized by their entrepreneurial spirit, often adopt direct-to-consumer sales strategies through avenues such as farmers markets, CSA programs, and agritourism ventures. In addition, experienced local growers may collaborate with wholesale distributors, florists, or event services to supply specialty flower varieties, leveraging their expertise and market connections.

Research conducted by Columbia & Stock in 2021 and Curtis & Stock in 2023 underscores the significance of these market trends and the strategic approaches adopted by players in the cut flower industry to meet evolving consumer demands and capitalize on emerging opportunities.

In terms of sales of cut flowers through online channel, there has been a notable surge in online flower purchases, attributed to the convenience and exceptional quality offered by digital platforms. This escalating trend is fueled by the ease with which customers can browse and buy flowers from the convenience of their homes, with just a few clicks.

Request a free sample copy or view report summary: Cut Flowers Market Report

Cut Flowers Market Report Highlights

  • The global cut flowers market is anticipated to experience the fastest CAGR during the forecast period, as it is fueled by the increasing use of cut flowers in events, special occasions, ceremonies, parties, and welcoming gestures
  • Based on product, the rose segment has a historical significance as a symbol of romance and ardor, with nearly every culture and religion attributing sentiments of love, passion, and longing to the red rose
  • Cut flowers serve as captivating focal points at home when arranged in vases or containers, adorning dining tables, coffee tables, or mantelpieces with natural beauty
  • Online flower shopping offers not just convenience but also time and effort savings. Through online flower delivery services, customers can easily send flowers directly to their desired recipients for birthdays, anniversaries, or any other significant occasion

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cut-flowers-market

Cut Flowers Market Segmentation

Grand View Research has segmented the global cut flowers market report based on product, application, distribution channel, and region:

Cut Flowers Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Rose
  • Chrysanthemum
  • Carnation
  • Gerbera
  • Lilium
  • Others

Cut Flowers Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Commercial
  • Home

Cut Flowers Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Supermarkets & Hypermarkets
  • Specialty Stores
  • Online
  • Others

Cut Flowers Regional Outlook (Revenue, USD Million; 2018 - 2030)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • South Korea
  • Central & South America (CSA)
    • Brazil
  • Middle East & Africa (MEA)
    • South Africa

List of Key Players of the Cut Flowers Market

  • The Queen’s Flowers Corp
  • Selecta Cut Flowers SAU
  • Sher Holland BV
  • Multiflora Corp
  • Rosebud Ltd
  • Karen Roses Ltd
  • Washington Bulb Co Inc
  • Dummen Orange Holding BV
  • Esmeralda Farms LLC
  • Marginpar BV

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Friday, 31 May 2024

Cat Litter Products Market to Penetrate Untapped Regions During 2024 to 2030: Grand View Research Inc.

Cat Litter Products Market Growth & Trends

The global cat litter products market size is expected to reach USD 22.31 billion by 2030, registering a CAGR of 5.1% from 2023 to 2030, according to a new report by Grand View Research, Inc. Pet ownership rates have been steadily increasing across the globe. Many people view pets as companions and part of the family, leading to higher adoption rates for dogs, cats, and other pets. This trend has fueled the demand for cat litter products and other pet care products and services.

According to the statistics published by the American Pet Products Association, Inc., in 2022, Generation Z accounted for 16% of pet ownership in the U.S., representing a noteworthy portion of the overall pet market. This indicates that Generation Z individuals have emerged as a significant consumer segment within the pet industry. The level of pet ownership among this demographic highlights their engagement and potential impact on the market.

The market is influenced by numerous technology trends that are revolutionizing cat care. Smart litter boxes with automated cleaning and health monitoring capabilities are gaining popularity, offering cat owners convenience and efficiency. Eco-friendly litter materials such as plant-based and biodegradable options are also being developed, addressing consumer demands for sustainability. Online platforms and mobile apps are enabling easy access and personalized shopping experiences. These advancements are enhancing functionality, eco-consciousness, and convenience in the market.

Manufacturers and key companies continuously innovate to meet the growing demand for natural options. For instance, in October 2020, MARS Petcare, the leading global pet food company, launched the CATSAN Hygiene Plus non-clumping litter brand in the Indian market. CATSAN, a trusted cat hygiene brand with over 30 years of experience, made its high-quality litter available to Indian pet parents through Amazon India's website. The non-clumping litter offers several key features, including triple odor protection with fine-pored hygiene granules that effectively soak up the liquid and keep the litter noticeably clean. It is made from select natural ingredients, free from bleach or scent, ensuring a 100% natural and safe product.

The emergence of direct selling marketing techniques is creating lucrative opportunities and widening the scope for market growth. Increasing focus on eliminating unnecessary middlemen has led to the development of initiatives such as the No Middleman Project. For instance, PrettyLitter caters directly to consumers, delivering value to cat parents in terms of time, cost, and effort. In addition, KitNipBox is a direct-to-consumer monthly cat subscription box with different subscription plans. Thus, a large number of companies in the market are adopting this channel to provide the ultimate level of convenience to cat parents. The rising penetration of the subscription-based business model also supports the market's growth.

Request a free sample copy or view report summary: Cat Litter Products Market Report

Cat Litter Products Market Report Highlights

  • Based on product type, the clumping segment is expected to witness substantial growth over the forecast period. The ability of clumping litter to form solid clumps when it comes in contact with any liquid makes it easier to scoop out the soiled litter, leaving behind clean and fresh litter
  • Based on raw material, the wood/bamboo/sawdust segment is expected to witness substantial growth over the forecast period from 2024 to 2030. This is due to their eco-friendly, biodegradable nature, which aligns with the increasing consumer demand for sustainable and natural pet care options
  • Based on distribution channel, the supermarkets and hypermarkets segment held the majority share in the overall sales channel in 2023 because of their wide reach, convenience, and ability to offer a diverse range of brands and options, making it easier for consumers to find and purchase cat litter products
  • The Asia Pacific region is anticipated to grow with the highest CAGR over the forecast period. The rise in disposable income allows pet owners to invest in premium and higher-priced cat litter products that offer better quality, performance, and convenience

Access Press Release@ https://www.grandviewresearch.com/press-release/global-cat-litter-products-market

Cat Litter Products Market Segmentation

Grand View Research has segmented the global cat litter products market on the basis of product type, raw materials, distribution channel and region

Cat Litter Products Product Type Outlook (USD Million; 2018 - 2030)

  • Clumping
  • Conventional

Cat Litter Products Raw Material Outlook (USD Million; 2018 - 2030)

  • Clay
  • Silica
  • Wood/Bamboo/Sawdust
  • Paper
  • Soy
  • Corn/Grain
  • Others

Cat Litter Products Distribution Channel Outlook (USD Million; 2018 - 2030)

  • Supermarkets and Hypermarkets
  • Specialty Retail Stores
  • Convenience Stores
  • Online/E-commerce

Cat Litter Products Regional Outlook (Revenue, USD Million; 2018 - 2030)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Taiwan
  • Central & South America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • UAE

List of Key Players in the Cat Litter Products Market

  • NestlĂ© S.A.
  • The Clorox Company
  • Mars, Incorporated
  • Oil-Dri Corporation of America
  • Church & Dwight Co., Inc.
  • Kent Corporation
  • Intersand
  • Elsey's
  • Weihai Pearl Silica Gel Co., Ltd.
  • Pettex Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Healthcare Contract Manufacturing Market Expected To Trigger A Revenue To $347.5 Billion By 2030: Grand View Research, Inc.

 Healthcare Contract Manufacturing Market Growth & Trends

The global healthcare contract manufacturing market size is expected to reach USD 347.5 billion by 2030, expanding at a CAGR of 9.5% during the forecast period, according to a new report by Grand View Research, Inc. The changing regulatory landscape coupled with rising offshoring to emerging countries is anticipated to propel the healthcare contract manufacturing market growth over the forecast period. For instance, in June 2023, FUJIFILM Diosynth Biotechnologies announced to have a commercial office in Tokyo, offering contract development and manufacturing services for advanced therapies and biologics to Asian pharmaceutical and biotechnology companies.     

Due to the emergence of infections, such as COVD-19 many organizations are attempting to accelerate production to meet the growing demand. Thus, these companies are appointing healthcare CMOs to speed up their production processes, as well as reduce their overall costs to meet the increasing demand for medical products. The worldwide effort to develop a vaccine and therapeutic agent against COVID-19 has created the greatest opportunity for many large as well as small CMOs as the pharmaceutical companies are manufacturing vaccine doses on large scale. Hence, the pandemic had a positive impact on this industry.

Increasing demand for advanced products is another factor driving the industry scale. Original Equipment Manufacturers (OEMs) are outsourcing the manufacturing activities of medical devices to third parties, mainly in developing countries to gain economic benefits. Furthermore, these regions are witnessing rising cases of chronic conditions such as heart disorders, thereby positively affecting the market growth. Changes in reimbursement schemes are some of the major factors anticipated to increase the adoption of cost containment measures by OEMs. For instance, to prevent reimbursement issues from impacting financing goals, device manufacturers are developing a well-planned reimbursement strategy in parallel with their regulatory and clinical strategies in the early phases of product development.

Request a free sample copy or view report summary: Healthcare Contract Manufacturing Market Report

Healthcare Contract Manufacturing Market Report Highlights

  • The pharmaceutical segment dominated the market with a share of 65.1% in 2022 owing to a low manufacturing budget and highly sophisticated contract manufacturing service offerings
  • The medical devices segment is expected to be the fastest-growing segment with a CAGR of 9.7% owing to increasing pressure on OEMs to reduce costs and enhance the timeline for taking a product to market
  • Cardiology is the dominant category in the medical device contract manufacturing segment, with a revenue share of 20.6% in 2022, owing to the rising demand for cardiovascular devices as a result of the increasing prevalence of associated heart conditions
  • Asia Pacific is expected to witness lucrative growth of 10.6% from 2023 to 2030, owing to the presence of a large number of service providers, lower costs, and growing demand for medical devices in the region
  • Based on end use segment, the pharmaceutical and biopharmaceutical companies category held the highest revenue share of 55.6% in 2022. High segment shares are mainly due to the increasing rate of biologics approval across the globe, thereby boosting demand for its bulk production contract manufacturing services

Access Press Release@ https://www.grandviewresearch.com/press-release/global-contract-manufacturing-market

Healthcare Contract Manufacturing Market Segmentation

Grand View Research has segmented the global healthcare contract manufacturing market based on type, end use, and region:

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Billion, 2018 - 2030)

  • Medical Devices
    • Service
      • Accessories manufacturing
      • Assembly manufacturing
      • Component manufacturing
      • Device manufacturing
    • Therapeutic Area
      • Cardiology
      • Diagnostic imaging
      • Orthopedic
      • IVD
      • Ophthalmic
      • General & plastic surgery
      • Drug delivery
      • Dental
      • Endoscopy
      • Diabetes care
      • Others
    • Pharmaceutical
      • API/Bulk Drugs
      • Advanced drug delivery formulations
      • Packaging
      • Finished dose formulations
        • Solid
        • Liquid
        • Semi-solid formulations

Healthcare Contract Manufacturing End-use Outlook (Revenue, USD Billion, 2018 - 2030)

  • Medical Device Companies
  • Pharmaceutical & Biopharmaceutical Companies
  • Others

Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2030)

  • North America
    • US.                
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
    • Belgium
    • Netherlands
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
    • Philippines
    • Malaysia
    • New Zealand
    • Singapore
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
    • Israel

List of Key Players of Healthcare Contract Manufacturing Market

  • Nordson Corporation
  • Integer Holdings Corporation
  • Jabil Inc.
  • Viant Technology LLC
  • FLEX LTD.
  • Celestica Inc.
  • Sanmina Corporation
  • Plexus Corp.
  • Phillips-Medisize
  • West Pharmaceutical Services, Inc.
  • Synecco Ltd
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Recipharm AB
  • Boehringer Ingelheim International GmbH
  • Lonza
  • Samsung Biologics
  • WuXi AppTec
  • FUJIFILM Diosynth Biotechnologies
  • Cambrex Corporation

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Base Station Antenna Market to Reach $25.58 Billion by 2030: Grand View Research Inc.

 Base Station Antenna Market Growth & Trends

The global base station antenna market size is expected to reach USD 25.58 billion by 2030, registering a CAGR of 17.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed to the faster development of mobile networks, which is being driven by rising demand for high-speed data transmission and the advent of new technologies such as 5G. As mobile operators attempt to improve network coverage and capacity, there is a rising demand for efficient and dependable base station antennas that can handle higher data rates and accommodate a greater number of connected devices.

The market is witnessing a shift towards advanced antenna technologies, including massive MIMO (Multiple Input Multiple Output), beamforming, and smart antennas. Massive MIMO adjusts antenna beam forms via 3D beamforming, concentrating radio power on target terminals within the target antenna coverage. This boosts spectral efficiency and sector-level throughput efficiently. Because of its high performance, massive MIMO is a key 5G technology. Massive MIMO is predicted to give network capacity 100 times more than existing LTE-A and LTE-A Pro solutions when mobile networks move to 5G.

Base station antennas are also designed to support advanced frequency bands, such as the millimeter wave (mmWave) bands used in 5G networks. These antennas enable high-speed data transmission and the exploitation of larger bandwidths available in these frequency ranges. Advanced frequency bands, including mmWave bands, offer significantly wider bandwidths than traditional frequency bands. This allows for higher data transmission rates, enabling applications that require ultra-fast data transfer, such as high-definition video streaming, Virtual Reality (VR), Augmented Reality (AR), and immersive gaming experiences.

The outbreak of the COVID-19 pandemic impacted the base station antenna market due to the disruptions of the supply chain functions. Despite the challenges, the pandemic highlighted the critical importance of reliable and high-speed connectivity. With remote work, online education, telemedicine, and increased digital activities, the demand for robust network infrastructure and base station antennas surged. The need to accommodate higher data traffic and ensure seamless connectivity prompted network operators to accelerate their investments in base station antennas.

Request a free sample copy or view report summary: Base Station Antenna Market Report

Base Station Antenna Market Report Highlights

  • The hardware segment dominated the market in 2022 owing to the advancements of sophisticated antenna designs and technologies to meet the ever-increasing needs of 5G networks which is a crucial element in driving the segment’s growth.
  • The 5G segment is projected to witness significant growth over the forecast period. The development of mmWave (millimeter-wave) base station antennas to support the higher frequencies used in 5G networks is adding to the segment's growth.
  • The urban segment dominated the market in 2022. There is a rising need for base station antennas in urban areas that can accommodate several wireless communication frequencies and technologies.
  • The mobile communication segment dominated the market in 2022 owing to the ability of Base station antennas to contribute to better signal strength and quality in mobile communication.
  • The North America segment is projected to witness significant growth over the forecast period. Network operators are investing heavily in 5G infrastructureto provide faster data speeds, lower latency, and support for emerging technologies like Internet of Things (IoT) and smart cities.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-base-station-antenna-market

Base Station Antenna Market Segmentation

Grand View Research has segmented the global base station antenna market based on offering, technology, provision, application, and region:

Base Station Antenna Offering Outlook (Volume, Units, Revenue, USD Billion, 2017 - 2030)

  • Hardware
    • Omni-Directional Antenna
    • Sector Antenna
    • Multibeam Antenna
    • Dipole Antenna
    • Small Cell
    • Others
  • Services

Base Station Antenna Technology Outlook (Volume, Units, Revenue, USD Billion, 2017 - 2030)

  • 3G
  • 4G/LTE
  • 5G

Base Station Antenna Provision Outlook (Volume, Units, Revenue, USD Billion, 2017 - 2030)

  • Urban
  • Semi-Urban
  • Rural

Base Station Antenna Application Outlook (Volume, Units, Revenue, USD Billion, 2017 - 2030)

  • Mobile Communication
  • Intelligent Transport
  • Industrial IoT
  • Smart City
  • Military & Defense
  • Others

Base Station Antenna Regional Outlook (Volume, Units, Revenue, USD Billion, 2017 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • UK.
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Kingdom of Saudi Arabia (KSA)
    • UAE
    • South Africa

List of Key Players in the Base Station Antenna Market

  • CommScope Holding Company, Inc.
  • Huawei Technologies Co., Ltd.
  • Amphenol Antenna Solutions
  • ACE Technologies Corp.
  • Comba Telecom Systems Holdings Ltd.
  • PCTEL Inc
  • Tongyu Communication Inc
  • Radio Frequency Systems (RFS)
  • Telefonaktiebolaget LM Ericsson
  • Kaelus

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Nanocellulose Market During 2023– 2030 to Gain Robust Traction: Grand View Research Inc.

 Nanocellulose Market Growth & Trends

The global nanocellulose market size is expected to reach USD 1,517.5 million by 2030 to expand at a CAGR of 20.1% from 2023 to 2030 as per the new report by Grand View Research, Inc. The industry growth is majorly driven by the growing concerns regarding the environment and the use of non-toxic and biodegradable packaging material. This shifting trend is anticipated to augment demand for bio-based products which will propel the demand the forecast period.

Nanocellulose has enormous potential for expansion in a variety of applications, including food packaging, composites, medicines, personal care, and others. However, the use of nanocellulose-based composites and paper processing has widened owing to its environmentally friendly properties.

Due to their physicochemical properties, cellulose nano fibrils are regarded as one of the greatest futuristic materials for the manufacture of textile products. These nano materials offer great stiffness, high strength, low coefficient of thermal expansion, chemical inertness, and the capacity to change their surface chemistry in addition to being renewable and naturally plentiful. Because of these features, manufacturers of textiles and nonwovens are mixing their traditional textiles with these Nano fibrils, propelling the market growth.

Additionally, CNC has the benefits of high strength, low density, high stiffness, biocompatibility, low thermal expansion coefficient, and renewable sources. Due to these benefits, nanocellulose application in composite materials has drawn more attention. Engineering plastics, biodegradable plastics, biomedical materials, water purification materials, and composites for electronic component applications are some of the major applications.

Growing need for sustainability has increased product demand in the manufacture of composites and packaging items. However, the pandemic had a significant impact on the market, particularly in the paper and pulp industries. The utilization declined when the demand for paper cut down owing to the global supply constraints on the product. However, the companies expanded into the production of personal protective equipment (PPE) such as masks and gowns utilizing non-woven derived from pulp, which directly led in increased demand for the nanocellulose.

Request a free sample copy or view report summary: Nanocellulose Market Report

Nanocellulose Market Report Highlights

  • The growth is attributed majorly due to the shifting trend towards sustainable packaging materials over synthetic materials
  • Europe dominated the global market in 2022 with a revenue share of 35%. This is attributed to increased industrialization and awareness of the usage of lighter and stronger packaging materials, derived from biodegradable sources, as well as technological advancements in this region
  • Cellulose Nanofibers (NFC, MFC) type segment dominated the market in 2022 contributing 50% to the global revenue. This is because when compared to other fibers, CNF is the most flexible, longest, and has the largest surface area
  • Pulp & paperboard application segment was the largest application segment in terms of revenue as it contributed 25% to the global revenue share. This is attributable to the high demand for alternate environment-friendly and durable packaging material.
  • The market is consolidated with the presence of a few players globally. Companies are investing in R&D to develop innovative products in-lined with the stringent environmental norms

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nanocellulose-market
Nanocellulose Market Segmentation

Grand View Research has segmented the global nanocellulose market report based on type, application, and region:

Nanocellulose Type Outlook (Revenue, USD Million; Volume, Tons; 2018 - 2030)

  • CNF (NFC, MFC)
  • Bacterial Cellulose
  • CNC

Nanocellulose Application Outlook (Revenue, USD Million; Volume, Tons; 2018 - 2030)

  • Pulp & Paperboard
  • Composites
  • Pharmaceuticals & Biomedical
  • Electronics
  • Food & Beverages
  • Others (Textile, Paints, cosmetics, Oil & Gas, Cement)

Nanocellulose Regional Outlook (Revenue, USD Million; Volume, Tons; 2018 - 2030)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • UK.
    • Germany
    • Netherlands
    • France
    • Finland
    • Norway
    • Sweden
    • Switzerland
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Thailand
    • Malaysia
    • Singapore
  • Central & South America
    • Brazil
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Israel
    • Iran

List of Key Players of Nanocellulose Market

  • Cellu Force
  • Fiber Lean
  • NIPPON PAPER INDUSTRIES CO., LTD.
  • Kruger INC
  • Borregaard AS
  • CelluComp
  • Melodea Ltd
  • Blue Goose Refineries
  • GranBio Technologies
  • Stora Enso Biomaterials

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Osteoarthritis Therapeutics Market To Hold a High Potential for Growth by 2030: Grand View Research Inc.

 Osteoarthritis Therapeutics Market Growth & Trends

The global osteoarthritis therapeutics market size is estimated to reach USD 13.57 billion by 2030 and is projected to grow at a CAGR of 6.82% from 2024 to 2030, according to a new report by Grand View Research, Inc.  The osteoarthritis therapeutics market is on the rise, driven by an increase in OA cases, especially among the aging population. In the U.S. alone, there are over 32.5 million OA patients, highlighting the demand for effective treatments. Ongoing research and development efforts are focused on creating new therapies, with a particular emphasis on understanding the disease and developing solutions to address its challenges.

Managing OA proves difficult owing to its dense tissue structure, but the introduction of novel drugs such as intra-articular drug administration has accelerated the development of targeted drug delivery. Researchers are actively exploring disease-modifying drugs and bioadaptive carriers to enhance the development of innovative osteoarthritis treatments. Market players are taking initiatives to contribute to market expansion, as seen with OrthoTrophix, Inc. presenting clinical data and a registration plan for TPX-100 for knee osteoarthritis at BIO 2022.

In addition, significant efforts are being made by key pharmaceutical companies and research institutes in realm of research and development, especially for disease-modifying osteoarthritis drugs. For instance, BioSenic's Phase 3 data presentation at the 2024 OARSI World Congress showcased the efficacy of JTA-004 in treating severe inflammatory knee osteoarthritis. The post hoc analysis concluded that JTA-004 is both safe and effective, offering targeted pain management for this specific subtype of condition. These advancements in targeted drug delivery and disease-modifying drugs, as demonstrated by presentations and positive trial results, are contributing to the expansion of the market for novel osteoarthritis treatments.

Moreover, the market for OA is experiencing significant growth owing to the introduction of personalized medications such as Bisphosphonates (anti-resorptive drugs) and Synvisc-ONE injection. In addition, pharmaceutical companies and research institutions are actively engaged in developing personalized treatments and cell-based therapies for OA. In December 2023, researchers at Columbia University made a breakthrough discovery of stem cells in adult mice capable of maintaining healthy cartilage in joints, with their decline contributing to OA development due to aging and injury.

Investing in this sector offers companies the opportunity to capitalize on evolving demands, thus gaining a competitive advantage. By leading innovative medication development, companies establish themselves as frontrunners, solidifying their position in the market. The advent of personalized OA medications and advancements in cell-based therapies are key drivers of market expansion, empowering companies to emerge as leaders in the field.

Request a free sample copy or view report summary: Osteoarthritis Therapeutics Market Report

Osteoarthritis Therapeutics Market Report Highlights

  • Based on drug type, the viscosupplementation agents segment led the market with the largest revenue share of 36.63% in 2023, osteoarthritis therapeutics market due to their adoption and efficacy in managing OA symptoms
  • Based on anatomy, the knee osteoarthritis segment held a market with the largest revenue share of 41.96% in 2023. Knee osteoarthritis is one of the most common forms of chronic articular disease and osteoarthritis worldwide and is characterized by high disability & morbidity rates
  • Based on route of administration, the parenteral route segment held the market with the largest revenue share of 39.94% in 2023 and is expected to grow at a CAGR of 7.50% over the forecast period, due to its efficacy for certain therapies, better pharmacokinetics and pharmacodynamics, and ease of administration
  • Based on end-use, the hospital pharmacies segment held the market with the largest revenue share of 47.64% in 2023, owing to high hospitalization associated with OA

Access Press Release@ https://www.grandviewresearch.com/press-release/global-osteoarthritis-therapeutics-market

Osteoarthritis Therapeutics Market Segmentation

Grand View Research has segmented the global osteoarthritis therapeutics market based on drug type, anatomy, route of administration, sales channel, end-use and region:

Osteoarthritis Therapeutics Drug Type Outlook (Revenue, USD Million, 2018 - 2030)

  • Viscosupplementation Agents
  • Nonsteroidal Anti-inflammatory Drugs
    • Naproxen
    • Aspirin
    • Diclofenac
    • Ibuprofen
    • Celecoxib
    • Meloxicam
    • Piroxicam
    • Ketoprofen
    • Other NSAIDs
  • Analgesics
    • Duloxetine
    • Acetaminophen
  • Corticosteroids
  • Others

Osteoarthritis Therapeutics Anatomy Outlook (Revenue, USD Million, 2018 - 2030)

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Hand Osteoarthritis
  • Others

Osteoarthritis Therapeutics Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

  • Parenteral Route
    • Hyaluronic Acid Injections
    • Corticosteroid Injections
    • Platelet-rich Plasma (PRP) Injections
    • Placental Tissue Matrix (PTM) Injections
    • Acetylsalicylic Acid (ASA) Injections
    • Others
  • Topical Route
  • Oral Route

Osteoarthritis Therapeutics Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Prescription Drugs
  • Over-the-Counter Drugs

Osteoarthritis Therapeutics End-use Outlook (Revenue, USD Million, 2018 - 2030)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Others

Osteoarthritis Therapeutics Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
    • Spain
    • France
    • Italy
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

List of Key Players in the Osteoarthritis Therapeutics Market

  • Sanofi SA
  • GlaxoSmithKline plc
  • Pfizer Inc
  • Bayer AG
  • Zimmer Biomet
  • Novartis AG
  • Anika Therapeutics
  • Assertio Therapeutics, INC.
  • Bioventus
  • Ferring Pharmaceuticals Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Vertical Farming: A Smart Solution for Food Security

  Vertical Farming: Redefining the Future of Sustainable Agriculture As the global population continues to grow and urbanization accelerates...